Rutika Mehta to Lead Upper GI Cancer Care and Research at NYU Langone
Gastrointestinal oncologist Rutika Mehta, MD, MPH, has been appointed director of upper GI medical oncology at NYU Langone Health's Perlmutter Cancer Center. The move expands the center's cancer care and research initiatives.
Rutika Mehta, MD, MPH, a recognized gastrointestinal (GI) medical oncologist, has joined NYU Langone Health's Perlmutter Cancer Center as director of upper GI medical oncology. In this role, she will lead and expand the center's clinical and research efforts focused on cancers of the upper digestive tract.
Mehta's appointment signifies an enhancement of NYU Langone's capabilities in treating and researching cancers of the esophagus, stomach, and duodenum. The Perlmutter Cancer Center aims to provide advanced treatment options and foster the development of new therapeutic strategies through ongoing clinical studies.
With extensive experience in both clinical patient care and cancer research, Mehta is expected to drive advancements in the field. Her focus will include developing more personalized treatment plans and improving outcomes for patients diagnosed with upper GI cancers.
The addition of Mehta is part of NYU Langone's strategy to strengthen its position as a leading center for complex cancer care and research, particularly in specialized areas like upper GI oncology.